Dr. Andrew Macann: Radiation oncologist on revolutionary cancer drug set to begin clinical trials

A revolutionary cancer drug developed in Auckland is set to begin clinical trials. Tarloxotinib is designed to help patients with head and neck cancers for which New Zealand ranks as one of the highest in the world for cases. Auckland City Hospital radiation oncologist Dr. Andrew Macann joined Mike Hosking. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Om Podcasten

Open your mind to the world with New Zealand’s number one breakfast radio show. Without question, as New Zealand’s number one talk host, Mike Hosking sets the day’s agenda. The sharpest voice and mind in the business, Mike drives strong opinion, delivers the best talent, and always leaves you wanting more. The Mike Hosking Breakfast always cuts through and delivers the best daily on Newstalk ZB.